Oramed Pharmaceuticals Inc. (ORMP)
Market Closed
15 Jun, 15:25
TASE 
1,108. 00
ILA -4
-0.3597%
- Market Cap
16.21 P/E Ratio
- Div Yield
1,802 Volume
-0.31 Eps
1,112 ILA
Previous Close Want to track ORMP and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
ORMP Earnings Reports FAQ
What is the earnings per share (EPS) for ORMP?
The current EPS is -0.31.
What is the company's earnings growth rate?
Oramed Pharmaceuticals Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Oramed Pharmaceuticals Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Oramed Pharmaceuticals Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for ORMP at this time, as Oramed Pharmaceuticals Inc has no recent EPS data to calculate it.
